“…The cross-over design also ensured that personal differences in heat tolerance did not confound the amount of time receiving cooling, as subjects and controls were the same participants. However, Vargas et al (2020) only performed this examination on females when they were in the first 10 days of their menstrual cycle, or in the first seven days of their hormonal birth control placebo phase. Although this was important to ensure that the body temperature increases associated with the elevation of progesterone levels did not confound thermoregulatory behaviour, this restricted inclusion criterion limits the generalizability of the study results in pre-menopausal adult women.…”